Paradigm Biocapital Advisors as of March 31, 2026
Portfolio Holdings for Paradigm Biocapital Advisors
Paradigm Biocapital Advisors holds 35 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arcellx Common Stock (ACLX) | 13.5 | $663M | 5.8M | 114.82 | |
| Revolution Medicines (RVMD) | 13.2 | $647M | 6.7M | 97.25 | |
| Nuvalent Inc-a (NUVL) | 11.1 | $546M | 5.3M | 102.45 | |
| Vaxcyte (PCVX) | 5.7 | $279M | 4.8M | 58.11 | |
| Edgewise Therapeutics (EWTX) | 4.7 | $232M | 7.4M | 31.50 | |
| Genmab A/s Sponsored Ads (GMAB) | 4.4 | $214M | 8.0M | 26.83 | |
| Insmed Com Par $.01 (INSM) | 4.2 | $205M | 1.3M | 163.52 | |
| Tarsus Pharmaceuticals (TARS) | 3.7 | $180M | 2.6M | 70.15 | |
| Belite Bio Sponsored Ads (BLTE) | 3.6 | $178M | 1.1M | 159.44 | |
| Erasca (ERAS) | 3.4 | $168M | 10M | 16.18 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 2.9 | $142M | 3.6M | 39.72 | |
| Olema Pharmaceuticals (OLMA) | 2.4 | $120M | 8.0M | 14.91 | |
| Terns Pharmaceuticals (TERN) | 2.4 | $117M | 2.2M | 52.72 | |
| Oruka Therapeutics (ORKA) | 2.3 | $114M | 2.3M | 49.05 | |
| Apogee Therapeutics (APGE) | 2.3 | $114M | 1.3M | 84.17 | |
| Spyre Therapeutics Com New (SYRE) | 2.0 | $99M | 2.0M | 50.44 | |
| Cytokinetics Com New (CYTK) | 2.0 | $98M | 1.5M | 65.91 | |
| Abivax Sa Sponsored Ads (ABVX) | 1.8 | $86M | 773k | 111.35 | |
| Tango Therapeutics (TNGX) | 1.7 | $84M | 4.0M | 20.92 | |
| Maze Therapeatics (MAZE) | 1.7 | $82M | 2.7M | 29.85 | |
| Tyra Biosciences (TYRA) | 1.6 | $79M | 2.1M | 38.30 | |
| Miragen Therapeutics (VRDN) | 1.3 | $62M | 3.1M | 19.56 | |
| Scholar Rock Hldg Corp (SRRK) | 1.2 | $60M | 1.2M | 49.16 | |
| Mirum Pharmaceuticals (MIRM) | 1.2 | $58M | 625k | 92.38 | |
| Eyepoint Com New (EYPT) | 0.8 | $41M | 3.1M | 12.89 | |
| Lexeo Therapeutics (LXEO) | 0.7 | $36M | 6.2M | 5.74 | |
| Veradermics Common Stock | 0.7 | $33M | 525k | 63.15 | |
| Vor Biopharma Com New (VOR) | 0.6 | $31M | 1.8M | 17.84 | |
| Urogen Pharma (URGN) | 0.6 | $31M | 1.7M | 17.98 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.5 | $26M | 545k | 48.20 | |
| Inventiva Sa Ads (IVA) | 0.5 | $22M | 4.0M | 5.55 | |
| Oric Pharmaceuticals (ORIC) | 0.4 | $22M | 1.7M | 12.67 | |
| Assembly Biosciences Com New (ASMB) | 0.4 | $19M | 665k | 27.75 | |
| Bridgebio Oncology Therapeut Com New (BBOT) | 0.2 | $7.8M | 868k | 8.95 | |
| Kalaris Therapeutics (KLRS) | 0.1 | $4.0M | 700k | 5.77 |
